Clinical trials
Recruiting Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,078 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 10 |
| 2018 | 12 |
| 2019 | 13 |
| 2020 | 27 |
| 2021 | 64 |
| 2022 | 98 |
| 2023 | 118 |
| 2024 | 205 |
| 2025 | 299 |
| 2026 | 206 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 1,078 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 21 |
| Sun Yat-sen University | 17 |
| Hunan Province Tumor Hospital | 16 |
| Memorial Sloan Kettering Cancer Center | 14 |
| Bristol-Myers Squibb | 13 |
| Merck Sharp & Dohme LLC | 13 |
| Fudan University | 12 |
| Tianjin Medical University Cancer Institute and Hospital | 12 |
| Shanghai Chest Hospital | 11 |
| National Cancer Institute (NCI) | 10 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 1,078 |
| Lung Neoplasms | 246 |
| Colorectal Neoplasms | 103 |
| Melanoma | 75 |
| Breast Neoplasms | 65 |
| Neoplasm Metastasis | 64 |
| Neoplasms | 62 |
| Squamous Cell Carcinoma of Head and Neck | 62 |
| Triple Negative Breast Neoplasms | 55 |
| Ovarian Neoplasms | 52 |
Trials
Showing 76 to 100 of 1,078. Each trial links to its page on Pharma Observatory.
978 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.